0
Osimertinib, platinum, and etoposide for patients with metastatic EGFR/TP53/RB1-mutant lung cancers at risk for histological transformation. (science.org)
Authors:
Gavarro LM
… Yu HA
Journal:
Science Translational Medicine
Published:
2026-11-11
DOI:
https://doi.org/10.1126/scitranslmed.aee6618
Comments
Login to comment.
No comments yet. Be the first!